Kaisa Huhtinen

ORCID: 0000-0001-9685-5246 · 20 papers in corpus
diagnostic-accuracy 2022
International journal of cancer ·doi:10.1002/ijc.34111

Our study reports the discovery and evaluation of nanoparticle aided sensitive assays for glycovariants of MUC16 and MUC1 in a unique collection of paired ovarian cyst fluids and serum samples obtained at or prior to surgery for ovarian car…

observational 2021
Cancers ·doi:10.3390/cancers13081764

Epithelial ovarian cancer (EOC) generally responds well to oncological treatments, but the eventual development of a refractory disease is a major clinical problem. Presently, there are no prognostic blood-based biomarkers for the stratific…

2020
·doi:10.6084/m9.figshare.12195975

Endometriosis is a common inflammatory estrogen-dependent gynecological disorder, associated with pelvic pain and reduced fertility in women. Several aspects of this disorder and its cellular and molecular etiology remain unresolved. We hav…

other 2020
Scientific data ·doi:10.1038/s41597-020-00623-x

Endometriosis is a common inflammatory estrogen-dependent gynecological disorder, associated with pelvic pain and reduced fertility in women. Several aspects of this disorder and its cellular and molecular etiology remain unresolved. We hav…

diagnostic-accuracy 2020
The journal of applied laboratory medicine ·doi:10.1093/jalm/jfz012

BACKGROUND: The cancer antigen 125 (CA125) immunoassay (IA) does not distinguish epithelial ovarian cancer (EOC) from benign disease with the sensitivity needed in clinical practice. In recent studies, glycoforms of CA125 have shown potenti…

diagnostic-accuracy 2020
Communications biology ·doi:10.1038/s42003-020-01191-x

Cancer antigen 125 (CA125) is a widely used biomarker in monitoring of epithelial ovarian cancer (EOC). Due to insufficient cancer specificity of CA125, its diagnostic use is severely compromised. Abnormal glycosylation of CA125 is a unique…

diagnostic-accuracy 2019
The journal of applied laboratory medicine ·doi:10.1373/jalm.2018.028266

BACKGROUND: The Sialyl-Thomsen-nouveau antigen (STn) is abundantly produced on many types of human epithelial cancers including epithelial ovarian cancer (EOC). We previously developed an EOC-specific lectin sandwich immunoassay (CA125MGL) …

other 2018
Human Reproduction ·doi:10.1093/humrep/dey026

STUDY QUESTION: What is the role of SFRP2 in endometriosis? SUMMARY ANSWER: SFRP2 acts as a canonical WNT/CTNNB1 signaling agonist in endometriosis, regulating endometriosis lesion growth and indicating endometriosis lesion borders togethe…

other 2016
Clinical chemistry ·doi:10.1373/clinchem.2016.257691

BACKGROUND: Measurement of serum cancer antigen 125 (CA125) is the standard approach for epithelial ovarian cancer (EOC) diagnostics and follow-up. However, the clinical specificity is not optimal because increased values are also detected …

observational 2014
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2014-1913

CONTEXT: Aberrant sex steroid signaling is suggested to promote endometriosis growth by several mechanisms, and the tissue concentrations of sex steroids are key determinants of the hormone action. However, their concentrations are only sup…

other 2014
Journal of proteome research ·doi:10.1021/pr500384n

New molecular information on potential therapeutic targets or tools for noninvasive diagnosis for endometriosis are important for patient care and treatment. However, surprisingly few efforts have described endometriosis at the protein leve…

observational 2012
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2012-1154

CONTEXT: Aberrant estrogen synthesis and metabolism have been suggested to increase local estradiol (E2) concentration in endometriosis and thus to promote the growth of the lesions. However, tissue estrogen concentrations within the endome…

observational 2012
Gynecologic Oncology ·doi:10.1016/j.ygyno.2012.03.011

OBJECTIVE: Human epididymal secretory protein E4 (HE4) is a new promising tumor marker developed for the diagnostics and follow up of ovarian cancer. It has yet to become widely accepted in clinical practice, and its biological properties h…

review 2011
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2011.08.022

Endometriosis is an estrogen-dependent gynecological disease where endometrium-like tissue grows outside uterine cavity. Endometriotic cell proliferation is stimulated by estrogens acting predominantly via their nuclear receptors. Estrogen …

other 2011
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2011.06.006

A fast and sensitive LC-MS/MS method for the quantitative analysis of seven steroid hormones in 150 μl of human serum was developed and validated. The following compounds were included: 17α-hydroxypregnenolone, 17α-hydroxyprogesterone, andr…

review 2011
Duodecim; laaketieteellinen aikakauskirja

Of women of reproductive age, 6 to 10% are estimated to be affected by endometriosis. Growth of tissue resembling the uterine mucosa outside the uterine cavity often causes severe menstrual pain, chronic pelvic pain and infertility for the …

2011
·doi:10.1210/endo-meetings.2011.part3.p25.p3-178
2010

Endometriosis is a common hormone-dependent gynecological disease leading to severe menstrual and/or chronic pelvic pain with or without subfertility. The disease is defined by the presence of endometrium-like tissue outside the uterine cav…

other 2009
Omics : a journal of integrative biology ·doi:10.1089/omi.2009.0027

Genome-scale molecular profiling of clinical sample material often results in heterogeneous datasets beyond the capability of standard statistical procedures. Statistical tests for differential expression, in particular, rely upon the assum…

other 2009
British journal of cancer ·doi:10.1038/sj.bjc.6605011

Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against ovarian endometriotic cysts is only superficially known. We, th…